Last 12 months
Inside the activity.
0 purchase rows · 33 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 4 |
| Mar 2026 | 0 | 5 |
| Apr 2026 | 0 | 2 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 3 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 5 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 22, 2021 Filed Feb 25, 2021 01:54 UTC |
Hopkinson Craig C.EVP R&D, Chief Medical Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 196,484 | $0.00 Strike: $19.73 | $0.00 |
DisclosureSEC source: 0001127602-21-007793 · form4.xml · derivative · entry 1 Hopkinson Craig C. · CIK 0001730048 · EVP R&D, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 196,484 Underlying: Ordinary Shares · 196,484 shares Expires 2031-02-22 F1 · derivative.exercise_date: Shares underlying the stock option vest and become exercisable in four equal annual installments commencing on 2/22/2022. Read SEC document |
| February 22, 2021 Filed Feb 25, 2021 01:53 UTC |
Gaffin David JosephSVP, CLO, Alkermes, Inc.
|
GrantRestricted Stock Unit Award · Derivative | 29,144 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-007792 · form4.xml · derivative · entry 2 Gaffin David Joseph · CIK 0001675905 · SVP, CLO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,144 Underlying: Ordinary Shares · 29,144 shares Expires not disclosed F2 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/22/2022. F2 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/22/2022. Read SEC document |
| February 22, 2021 Filed Feb 25, 2021 01:53 UTC |
Gaffin David JosephSVP, CLO, Alkermes, Inc.
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 118,925 | $0.00 Strike: $19.73 | $0.00 |
DisclosureSEC source: 0001127602-21-007792 · form4.xml · derivative · entry 1 Gaffin David Joseph · CIK 0001675905 · SVP, CLO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,925 Underlying: Ordinary Shares · 118,925 shares Expires 2031-02-22 F1 · derivative.exercise_date: Shares underlying the stock option vest and become exercisable in four equal annual installments commencing on 2/22/2022. Read SEC document |
| February 22, 2021 Filed Feb 25, 2021 01:52 UTC |
Brown Iain MichaelSVP, Chief Financial Officer
|
GrantRestricted Stock Unit Award · Derivative | 27,877 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-007791 · form4.xml · derivative · entry 2 Brown Iain Michael · CIK 0001643456 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,877 Underlying: Ordinary Shares · 27,877 shares Expires not disclosed F2 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/22/2022. F2 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/22/2022. Read SEC document |
| February 22, 2021 Filed Feb 25, 2021 01:52 UTC |
Brown Iain MichaelSVP, Chief Financial Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 113,754 | $0.00 Strike: $19.73 | $0.00 |
DisclosureSEC source: 0001127602-21-007791 · form4.xml · derivative · entry 1 Brown Iain Michael · CIK 0001643456 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,754 Underlying: Ordinary Shares · 113,754 shares Expires 2031-02-22 F1 · derivative.exercise_date: Shares underlying the stock option vest and become exercisable in four equal annual installments commencing on 2/22/2022. Read SEC document |
| February 21, 2021 Filed Feb 24, 2021 02:37 UTC |
POPS RICHARD FDirector · Director and CEO, Alkermes plc
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 32,400 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-007462 · form4.xml · derivative · entry 3 POPS RICHARD F · CIK 0001126490 · Director · Director and CEO, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,800 Underlying: Ordinary Shares · 32,400 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/21/2020. F1 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/21/2020. Read SEC document |
| February 21, 2021 Filed Feb 24, 2021 02:37 UTC |
POPS RICHARD FDirector · Director and CEO, Alkermes plc
|
Tax withholdingOrdinary Shares | 14,386 | $19.58 | $281,677.88 |
DisclosureSEC source: 0001127602-21-007462 · form4.xml · nonDerivative · entry 2 POPS RICHARD F · CIK 0001126490 · Director · Director and CEO, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 792,040 Read SEC document |
| February 21, 2021 Filed Feb 24, 2021 02:37 UTC |
POPS RICHARD FDirector · Director and CEO, Alkermes plc
|
Exercise / conversionOrdinary Shares | 32,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-007462 · form4.xml · nonDerivative · entry 1 POPS RICHARD F · CIK 0001126490 · Director · Director and CEO, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 806,426 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 21, 2021 Filed Feb 23, 2021 21:36 UTC |
LANDINE MICHAEL JSVP, Corp Dev., Alkermes, Inc.
|
Tax withholdingOrdinary Shares | 2,587 | $19.58 | $50,653.46 |
DisclosureSEC source: 0001127602-21-007460 · form4.xml · nonDerivative · entry 4 LANDINE MICHAEL J · CIK 0001235600 · SVP, Corp Dev., Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 216,781 Read SEC document |
| February 21, 2021 Filed Feb 24, 2021 02:29 UTC |
Jackson Blair CurtisEVP, Chief Operating Officer
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 4,800 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-007459 · form4.xml · derivative · entry 6 Jackson Blair Curtis · CIK 0001842348 · EVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,600 Underlying: Ordinary Shares · 4,800 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/21/2020. F2 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/21/2020. Read SEC document |
| February 21, 2021 Filed Feb 24, 2021 02:29 UTC |
Jackson Blair CurtisEVP, Chief Operating Officer
|
Tax withholdingOrdinary Shares | 1,412 | $19.58 | $27,646.96 |
DisclosureSEC source: 0001127602-21-007459 · form4.xml · nonDerivative · entry 4 Jackson Blair Curtis · CIK 0001842348 · EVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,154 Read SEC document |
| February 21, 2021 Filed Feb 24, 2021 02:29 UTC |
Jackson Blair CurtisEVP, Chief Operating Officer
|
Exercise / conversionOrdinary Shares | 4,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-007459 · form4.xml · nonDerivative · entry 3 Jackson Blair Curtis · CIK 0001842348 · EVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,566 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 21, 2021 Filed Feb 24, 2021 02:25 UTC |
Hopkinson Craig C.EVP R&D, Chief Medical Officer
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 6,875 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-007458 · form4.xml · derivative · entry 6 Hopkinson Craig C. · CIK 0001730048 · EVP R&D, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,750 Underlying: Ordinary Shares · 6,875 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/21/2020. F2 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/21/2020. Read SEC document |
| February 21, 2021 Filed Feb 24, 2021 02:25 UTC |
Hopkinson Craig C.EVP R&D, Chief Medical Officer
|
Tax withholdingOrdinary Shares | 2,022 | $19.58 | $39,590.76 |
DisclosureSEC source: 0001127602-21-007458 · form4.xml · nonDerivative · entry 4 Hopkinson Craig C. · CIK 0001730048 · EVP R&D, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,920 Read SEC document |
| February 21, 2021 Filed Feb 24, 2021 02:25 UTC |
Hopkinson Craig C.EVP R&D, Chief Medical Officer
|
Exercise / conversionOrdinary Shares | 6,875 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-007458 · form4.xml · nonDerivative · entry 3 Hopkinson Craig C. · CIK 0001730048 · EVP R&D, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,942 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 21, 2021 Filed Feb 24, 2021 02:25 UTC |
Gaffin David JosephSVP, CLO, Alkermes, Inc.
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 6,875 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-007457 · form4.xml · derivative · entry 6 Gaffin David Joseph · CIK 0001675905 · SVP, CLO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,750 Underlying: Ordinary Shares · 6,875 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/21/2020. F2 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/21/2020. Read SEC document |
| February 21, 2021 Filed Feb 24, 2021 02:25 UTC |
Gaffin David JosephSVP, CLO, Alkermes, Inc.
|
Tax withholdingOrdinary Shares | 2,022 | $19.58 | $39,590.76 |
DisclosureSEC source: 0001127602-21-007457 · form4.xml · nonDerivative · entry 4 Gaffin David Joseph · CIK 0001675905 · SVP, CLO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,597 Read SEC document |
| February 21, 2021 Filed Feb 24, 2021 02:25 UTC |
Gaffin David JosephSVP, CLO, Alkermes, Inc.
|
Exercise / conversionOrdinary Shares | 6,875 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-007457 · form4.xml · nonDerivative · entry 3 Gaffin David Joseph · CIK 0001675905 · SVP, CLO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,619 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 21, 2021 Filed Feb 24, 2021 02:24 UTC |
Brown Iain MichaelSVP, Chief Financial Officer
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 4,800 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-007456 · form4.xml · derivative · entry 6 Brown Iain Michael · CIK 0001643456 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,600 Underlying: Ordinary Shares · 4,800 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/21/2020. F2 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/21/2020. Read SEC document |
| February 21, 2021 Filed Feb 24, 2021 02:24 UTC |
Brown Iain MichaelSVP, Chief Financial Officer
|
Tax withholdingOrdinary Shares | 1,412 | $19.58 | $27,646.96 |
DisclosureSEC source: 0001127602-21-007456 · form4.xml · nonDerivative · entry 4 Brown Iain Michael · CIK 0001643456 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,362 Read SEC document |
| February 21, 2021 Filed Feb 24, 2021 02:24 UTC |
Brown Iain MichaelSVP, Chief Financial Officer
|
Exercise / conversionOrdinary Shares | 4,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-007456 · form4.xml · nonDerivative · entry 3 Brown Iain Michael · CIK 0001643456 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,774 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 20, 2021 Filed Feb 24, 2021 02:55 UTC |
Nichols Christian ToddSVP, Chief Commercial Officer
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 3,824 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-007466 · form4.xml · derivative · entry 3 Nichols Christian Todd · CIK 0001813312 · SVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,473 Underlying: Ordinary Shares · 3,824 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/20/2021. F1 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/20/2021. Read SEC document |
| February 20, 2021 Filed Feb 24, 2021 02:55 UTC |
Nichols Christian ToddSVP, Chief Commercial Officer
|
Tax withholdingOrdinary Shares | 1,292 | $19.58 | $25,297.36 |
DisclosureSEC source: 0001127602-21-007466 · form4.xml · nonDerivative · entry 2 Nichols Christian Todd · CIK 0001813312 · SVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,003 Read SEC document |
| February 20, 2021 Filed Feb 24, 2021 02:55 UTC |
Nichols Christian ToddSVP, Chief Commercial Officer
|
Exercise / conversionOrdinary Shares | 3,824 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-007466 · form4.xml · nonDerivative · entry 1 Nichols Christian Todd · CIK 0001813312 · SVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,295 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 20, 2021 Filed Feb 23, 2021 21:36 UTC |
LANDINE MICHAEL JSVP, Corp Dev., Alkermes, Inc.
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 5,825 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-007460 · form4.xml · derivative · entry 6 LANDINE MICHAEL J · CIK 0001235600 · SVP, Corp Dev., Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,650 Underlying: Ordinary Shares · 5,825 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/21/2020. F2 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/21/2020. Read SEC document |
| February 20, 2021 Filed Feb 23, 2021 21:36 UTC |
LANDINE MICHAEL JSVP, Corp Dev., Alkermes, Inc.
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 5,353 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-007460 · form4.xml · derivative · entry 5 LANDINE MICHAEL J · CIK 0001235600 · SVP, Corp Dev., Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,062 Underlying: Ordinary Shares · 5,353 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/20/2021. F1 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/20/2021. Read SEC document |
| February 20, 2021 Filed Feb 23, 2021 21:36 UTC |
LANDINE MICHAEL JSVP, Corp Dev., Alkermes, Inc.
|
Exercise / conversionOrdinary Shares | 5,825 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-007460 · form4.xml · nonDerivative · entry 3 LANDINE MICHAEL J · CIK 0001235600 · SVP, Corp Dev., Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 219,368 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 20, 2021 Filed Feb 23, 2021 21:36 UTC |
LANDINE MICHAEL JSVP, Corp Dev., Alkermes, Inc.
|
Tax withholdingOrdinary Shares | 2,360 | $19.58 | $46,208.80 |
DisclosureSEC source: 0001127602-21-007460 · form4.xml · nonDerivative · entry 2 LANDINE MICHAEL J · CIK 0001235600 · SVP, Corp Dev., Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 213,543 Read SEC document |
| February 20, 2021 Filed Feb 23, 2021 21:36 UTC |
LANDINE MICHAEL JSVP, Corp Dev., Alkermes, Inc.
|
Exercise / conversionOrdinary Shares | 5,353 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-007460 · form4.xml · nonDerivative · entry 1 LANDINE MICHAEL J · CIK 0001235600 · SVP, Corp Dev., Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 215,903 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 20, 2021 Filed Feb 24, 2021 02:29 UTC |
Jackson Blair CurtisEVP, Chief Operating Officer
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 4,589 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-007459 · form4.xml · derivative · entry 5 Jackson Blair Curtis · CIK 0001842348 · EVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,767 Underlying: Ordinary Shares · 4,589 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/20/2021. F1 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/20/2021. Read SEC document |
| February 20, 2021 Filed Feb 24, 2021 02:29 UTC |
Jackson Blair CurtisEVP, Chief Operating Officer
|
Tax withholdingOrdinary Shares | 1,374 | $19.58 | $26,902.92 |
DisclosureSEC source: 0001127602-21-007459 · form4.xml · nonDerivative · entry 2 Jackson Blair Curtis · CIK 0001842348 · EVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,766 Read SEC document |
| February 20, 2021 Filed Feb 24, 2021 02:29 UTC |
Jackson Blair CurtisEVP, Chief Operating Officer
|
Exercise / conversionOrdinary Shares | 4,589 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-007459 · form4.xml · nonDerivative · entry 1 Jackson Blair Curtis · CIK 0001842348 · EVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,140 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 20, 2021 Filed Feb 24, 2021 02:25 UTC |
Hopkinson Craig C.EVP R&D, Chief Medical Officer
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 10,095 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-007458 · form4.xml · derivative · entry 5 Hopkinson Craig C. · CIK 0001730048 · EVP R&D, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,287 Underlying: Ordinary Shares · 10,095 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/20/2021. F1 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/20/2021. Read SEC document |
| February 20, 2021 Filed Feb 24, 2021 02:25 UTC |
Hopkinson Craig C.EVP R&D, Chief Medical Officer
|
Tax withholdingOrdinary Shares | 3,064 | $19.58 | $59,993.12 |
DisclosureSEC source: 0001127602-21-007458 · form4.xml · nonDerivative · entry 2 Hopkinson Craig C. · CIK 0001730048 · EVP R&D, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,067 Read SEC document |
| February 20, 2021 Filed Feb 24, 2021 02:25 UTC |
Hopkinson Craig C.EVP R&D, Chief Medical Officer
|
Exercise / conversionOrdinary Shares | 10,095 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-007458 · form4.xml · nonDerivative · entry 1 Hopkinson Craig C. · CIK 0001730048 · EVP R&D, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,131 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 20, 2021 Filed Feb 24, 2021 02:25 UTC |
Gaffin David JosephSVP, CLO, Alkermes, Inc.
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 7,036 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-007457 · form4.xml · derivative · entry 5 Gaffin David Joseph · CIK 0001675905 · SVP, CLO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,109 Underlying: Ordinary Shares · 7,036 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/20/2021. F1 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/20/2021. Read SEC document |
| February 20, 2021 Filed Feb 24, 2021 02:25 UTC |
Gaffin David JosephSVP, CLO, Alkermes, Inc.
|
Tax withholdingOrdinary Shares | 2,061 | $19.58 | $40,354.38 |
DisclosureSEC source: 0001127602-21-007457 · form4.xml · nonDerivative · entry 2 Gaffin David Joseph · CIK 0001675905 · SVP, CLO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,744 Read SEC document |
| February 20, 2021 Filed Feb 24, 2021 02:25 UTC |
Gaffin David JosephSVP, CLO, Alkermes, Inc.
|
Exercise / conversionOrdinary Shares | 7,036 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-007457 · form4.xml · nonDerivative · entry 1 Gaffin David Joseph · CIK 0001675905 · SVP, CLO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,805 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 20, 2021 Filed Feb 24, 2021 02:24 UTC |
Brown Iain MichaelSVP, Chief Financial Officer
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 4,589 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-007456 · form4.xml · derivative · entry 5 Brown Iain Michael · CIK 0001643456 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,767 Underlying: Ordinary Shares · 4,589 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/20/2021. F1 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/20/2021. Read SEC document |
| February 20, 2021 Filed Feb 24, 2021 02:24 UTC |
Brown Iain MichaelSVP, Chief Financial Officer
|
Tax withholdingOrdinary Shares | 1,378 | $19.58 | $26,981.24 |
DisclosureSEC source: 0001127602-21-007456 · form4.xml · nonDerivative · entry 2 Brown Iain Michael · CIK 0001643456 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,974 Read SEC document |
| February 20, 2021 Filed Feb 24, 2021 02:24 UTC |
Brown Iain MichaelSVP, Chief Financial Officer
|
Exercise / conversionOrdinary Shares | 4,589 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-007456 · form4.xml · nonDerivative · entry 1 Brown Iain Michael · CIK 0001643456 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,352 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 17, 2021 Filed Feb 19, 2021 00:28 UTC |
POPS RICHARD FDirector · Director and CEO, Alkermes plc
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 8,750 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-006566 · form4.xml · derivative · entry 6 POPS RICHARD F · CIK 0001126490 · Director · Director and CEO, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 8,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/17/2018. F2 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/17/2018. Read SEC document |
| February 17, 2021 Filed Feb 19, 2021 00:28 UTC |
POPS RICHARD FDirector · Director and CEO, Alkermes plc
|
Tax withholdingOrdinary Shares | 3,869 | $19.97 | $77,263.93 |
DisclosureSEC source: 0001127602-21-006566 · form4.xml · nonDerivative · entry 4 POPS RICHARD F · CIK 0001126490 · Director · Director and CEO, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 774,026 Read SEC document |
| February 17, 2021 Filed Feb 19, 2021 00:28 UTC |
POPS RICHARD FDirector · Director and CEO, Alkermes plc
|
Exercise / conversionOrdinary Shares | 8,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-006566 · form4.xml · nonDerivative · entry 3 POPS RICHARD F · CIK 0001126490 · Director · Director and CEO, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 777,895 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 17, 2021 Filed Feb 18, 2021 19:27 UTC |
LANDINE MICHAEL JSVP, Corp Dev., Alkermes, Inc.
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 3,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-006565 · form4.xml · derivative · entry 6 LANDINE MICHAEL J · CIK 0001235600 · SVP, Corp Dev., Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 3,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/17/2018. F2 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/17/2018. Read SEC document |
| February 17, 2021 Filed Feb 18, 2021 19:27 UTC |
LANDINE MICHAEL JSVP, Corp Dev., Alkermes, Inc.
|
Tax withholdingOrdinary Shares | 1,492 | $19.97 | $29,795.24 |
DisclosureSEC source: 0001127602-21-006565 · form4.xml · nonDerivative · entry 4 LANDINE MICHAEL J · CIK 0001235600 · SVP, Corp Dev., Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 210,550 Read SEC document |
| February 17, 2021 Filed Feb 18, 2021 19:27 UTC |
LANDINE MICHAEL JSVP, Corp Dev., Alkermes, Inc.
|
Exercise / conversionOrdinary Shares | 3,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-006565 · form4.xml · nonDerivative · entry 3 LANDINE MICHAEL J · CIK 0001235600 · SVP, Corp Dev., Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 212,042 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 17, 2021 Filed Feb 19, 2021 00:26 UTC |
Jackson Blair CurtisEVP, Chief Operating Officer
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 2,250 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-006564 · form4.xml · derivative · entry 6 Jackson Blair Curtis · CIK 0001842348 · EVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 2,250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/17/2018. F2 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/17/2018. Read SEC document |
| February 17, 2021 Filed Feb 19, 2021 00:26 UTC |
Jackson Blair CurtisEVP, Chief Operating Officer
|
Tax withholdingOrdinary Shares | 781 | $19.97 | $15,596.57 |
DisclosureSEC source: 0001127602-21-006564 · form4.xml · nonDerivative · entry 4 Jackson Blair Curtis · CIK 0001842348 · EVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,551 Read SEC document |
| February 17, 2021 Filed Feb 19, 2021 00:26 UTC |
Jackson Blair CurtisEVP, Chief Operating Officer
|
Exercise / conversionOrdinary Shares | 2,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-006564 · form4.xml · nonDerivative · entry 3 Jackson Blair Curtis · CIK 0001842348 · EVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,332 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.